Biogen Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€114.05
Target price
01.08.26
€191.89
Performance (%)
0.00%
Price
01.08.25
€114.05
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Biogen Inc. is currently unchanged. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 0.00% |
| iShares Core DAX® | -3.352% |
| iShares Nasdaq 100 | -0.740% |
| iShares Nikkei 225® | -1.885% |
| iShares S&P 500 | -0.952% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat